HYCC1
Hyccin
Also known as: DRCTNNB1A, FAM126A, HCC, HYCCI_HUMAN, hyccin
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BYI3
- Gene
- HYCC1
- Ensembl
- ENSG00000122591
- Chromosome
- 7
- Canonical length
- 521 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene may play a part in the beta-catenin/Lef signaling pathway. Expression of this gene is down-regulated by beta-catenin. Defects in this gene are a cause of hypomyelination with congenital cataract (HCC). [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
521 residues, UniProt reviewed canonical sequence.
>Q9BYI3|HYCC1
1 MFTSEKGVVE EWLSEFKTLP ETSLPNYATN LKDKSSLVSS LYKVIQEPQS ELLEPVCHQL
61 FEFYRSGEEQ LLQFTLQFLP ELIWCYLAVS ASRNVHSSGC IEALLLGVYN LEIVDKQGHT
121 KVLSFTIPSL SKPSVYHEPS SIGSMALTES ALSQHGLSKV VYSGPHPQRE MLTAQNRFEV
181 LTFLLLCYNA ALTYMPSVSL QSLCQICSRI CVCGYPRQHV RKYKGISSRI PVSSGFMVQM
241 LTGIYFAFYN GEWDLAQKAL DDIIYRAQLE LYPEPLLVAN AIKASLPHGP MKSNKEGTRC
301 IQVEITPTSS RISRNAVTSM SIRGHRWKRH GNTELTGQEE LMEISEVDEG FYSRAASSTS
361 QSGLSNSSHN CSNKPSIGKN HRRSGGSKTG GKEKETTGES CKDHFARKQT QRAQSENLEL
421 LSLKRLTLTT SQSLPKPSSH GLAKTAATVF SKSFEQVSGV TVPHNPSSAV GCGAGTDANR
481 FSACSLQEEK LIYVSERTEL PMKHQSGQQR PPSISITLST DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HYCC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 21 nTPM
- tongue: 14 nTPM
- placenta: 14 nTPM
- blood vessel: 12 nTPM
- breast: 11 nTPM
- esophagus: 11 nTPM
Single-cell type
- pituicytes/fscs: 571 nCPM
- retinal pigment epithelial cells: 264 nCPM
- melanocytes: 257 nCPM
- choroid plexus epithelial cells: 253 nCPM
- esophageal apical cells: 249 nCPM
- schwann cells: 248 nCPM
Immune cell
- eosinophil: 14 nTPM
- non-classical monocyte: 9.9 nTPM
- intermediate monocyte: 7.9 nTPM
- naive B-cell: 7.4 nTPM
- memory B-cell: 6.5 nTPM
- basophil: 4.8 nTPM
Brain region
- hippocampal formation: 25 nTPM
- choroid plexus: 16 nTPM
- white matter: 16 nTPM
- basal ganglia: 14 nTPM
- hypothalamus: 13 nTPM
- thalamus: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HYCC1.
Disease | AllUniProt
Conditions HYCC1 is implicated in, by any mechanism.
- Leukodystrophy, hypomyelinating, 5 (HLD5) MIM:610532
Disease | GeneticClinVar
21 pathogenic / likely-pathogenic of 396 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hypomyelination and Congenital Cataract
- Tooth agenesis, selective, X-linked, 1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0.12
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- myelination
- phosphatidylinositol phosphate biosynthetic process
- protein localization to plasma membrane
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HYCC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HYCC1 as an antibody target. Whether an autoantibody or antibody against HYCC1 could matter depends on whether native HYCC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HYCC1 is annotated at the cell surface, where native HYCC1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label HYCC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...